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Background: The only curative therapy for renal cell carcinoma is the complete removal of malignant tissue.
Surgical bleeding during radical nephrectomy may require blood transfusion. Blood transfusion, however, is
associated with postoperative morbidity and mortality. This study investigated predictive factors of transfusion
requirement in patients undergoing radical nephrectomy, as well as the effects of transfusion on postoperative
outcomes.
Methods: This study retrospectively enrolled 526 patients who underwent open radical nephrectomy for renal cell
carcinoma between 2010 and 2012. Univariate and multivariate logistic regression analyses were used to determine
independent predictive factors of a requirement for packed red blood cell (PRBC) transfusion. Postoperative
outcomes included an admission to the intensive care unit (ICU) and lengths of ICU and hospital stay.
Results: Of the 526 patients, 93 (17.7 %) required PRBC transfusion, with these patients requiring a mean 5.5
units. Preoperative hypoalbuminemia (serum albumin <3.5 g/dL) was observed in 75 (14.3 %) patients, and
preoperative anemia (hemoglobin <12.0 g/dL) in 121 (23.0 %). Multivariate logistic regression analysis showed
that preoperative hypoalbuminemia, preoperative anemia, and a high cancer stage were independent factors
significantly associated with PRBC transfusion in open radical nephrectomy. The transfused group had higher
incidence of ICU admission and longer lengths of ICU and hospital stay than the non-transfused group.
Conclusions: Preoperative hypoalbuminemia and anemia are important predictors of PRBC transfusion during
radical nephrectomy for renal cell carcinoma. Furthermore, transfusion is associated with poor postoperative
outcomes.
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Renal cell carcinoma, the most common form of kidney
cancer, initially has an asymptomatic clinical course;
thus, 25–30 % of patients present with metastatic disease
at the time of diagnosis [1]. However, the increased
utilization of abdominal radiologic imaging has led to an
ever-growing proportion of incidentally discovered renal
tumors. Since radical nephrectomy for localized renal
masses results in excellent long-term prognosis, there
have been steady advances in surgical techniques that* Correspondence: kyk@amc.seoul.kr
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these tumors [2]. However, despite improvements in pre-
operative diagnostic modalities, anesthetic management,
and perioperative care, the morbidity and mortality rates
remain high, primarily due to hemorrhage and pulmonary
embolism [3]. Therefore, it is important to identify factors
predicting hemorrhage and subsequent blood transfusion,
which may be associated with postoperative outcomes.
Most previous reports on nephrectomy have focused
on the occurrence of postoperative complications [4–6];
however, information about factors predictive of intraop-
erative blood transfusion is limited. Therefore, the
present study examined factors predictive of a require-
ment for packed red blood cell (PRBC) transfusion inle distributed under the terms of the Creative Commons Attribution License
which permits unrestricted use, distribution, and reproduction in any medium,
. The Creative Commons Public Domain Dedication waiver (http://
) applies to the data made available in this article, unless otherwise stated.
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cell carcinoma, as well as the effects of PRBC transfu-




This study retrospectively reviewed the electronic medical
records and laboratory results of all patients who under-
went open radical nephrectomy for renal cell carcinoma
at our institution between January 2010 and December
2012. We excluded the patients who underwent open
partial nephrectomy, laparoscopic partial/radical nephrec-
tomy or hand assisted laparoscopic surgery. The study
protocol was approved by the Institutional Review Board
of Asan Medical Center (AMC IRB-2013-0533).
During the study period, 548 patients with suspected
kidney cancer underwent open radical nephrectomy. How-
ever, 6 patients who did not perform preoperative abdom-
inal computed tomography (CT) and 4 patients with
double primary renal cell carcinoma involving both kidneys
were excluded. Furthermore, 12 patients with different
pathologic diagnosis; 5 patients with metastatic renal nod-
ule from lung or liver, 5 patients with ureter caner, 1 patient
with transitional cell carcinoma in kidney and 1 patient
with malignant mixed mullerian tumor, were excluded.
Finally, a total of 526 patients were included. Demographic
variables included patient age, gender, body mass index,
history of hypertension, diabetes or abdominal surgery,
coronary artery disease defined as stenosis of one or more
coronary arteries with >50 % occlusion of the vessel lumen,
and respiratory disease including chronic obstructive pul-
monary disease, history of tuberculosis, asthma or intersti-
tial lung disease. The standard preoperative evaluation at
our institution included a clinical examination, chest X-ray,
electrocardiography, complete blood counts, liver and renal
function tests, coagulation profile, and viral serology. Renal
cell carcinomas were staged based on preoperative imaging
[7]. Nine patients without formal records of imaging find-
ings did not have their cancer stage because they were
diagnosed from other centers before visiting our center.
Tumor size was also evaluated by abdominal CT.
Anesthesia
Following the application of routine hemodynamic mon-
itoring, general anesthesia was induced with thiopental,
fentanyl, and rocuronium. After endotracheal intubation,
patients were mechanically ventilated and their radial
arterial pressure was monitored. Large bore intravenous
lines were secured in all patients for fluid management.
General anesthesia was maintained with volatile anes-
thetics, except in 14 patients who were maintained with
total intravenous anesthesia, consisting of continuous tar-
get controlled infusion of propofol and remifentanil. Fluidmanagement was performed using crystalloids and col-
loids. During anesthesia, patients were maintained at an
arterial systolic blood pressure (SBP) of ≥90 mmHg and a
hemoglobin concentration of ≥8.0 g/dL.
Surgical procedure
Patients undergoing open radical nephrectomy with or
without tumor thrombectomy were identified and their
clinicopathological variables were recorded. Surgical in-
cision was chosen based on an optimal approach to the
tumor and vascular control. Open radical nephrectomy
was performed in a standard manner by 4 urologists.
Tumor thrombectomy was performed in 23 patients
with venous thrombi. Five patients with a level IV tumor
thrombus adherent to the right atrial wall also under-
went cardiopulmonary bypass.
PRBC transfusion criteria and postoperative outcomes
Intraoperative transfusion was performed in accordance
with standard transfusion guidelines [8]. Indications for
PRBC transfusion included an intraoperative hemoglobin
concentration <8 g/dL. The incidence of intraoperative
PRBC transfusion was determined from electronic med-
ical records. Furthermore, creatinine levels which are the
highest values within 3 postoperative days, pulmonary
complications (such as fever >37.5 °C or atelectasis on
chest X-ray, dyspnea, respiratory failure, and postoperative
hypoxia up until 3 days after surgery) [9] and postopera-
tive outcomes were evaluated. Postoperative outcomes in-
cluded an admission to the intensive care unit (ICU) and
lengths of ICU and hospital stay.
Statistical analysis
Continuous variables were expressed as the mean ± stand-
ard deviation or number (percentage). Categorical data
were analyzed using the χ2 or Fisher’s exact tests. Univariate
logistic regression analysis was used to identify demo-
graphic, preoperative laboratory, and intraoperative factors
significantly associated with PRBC transfusion requirement.
Variables with a P value <0.05 in univariate analysis were
included in the multivariate logistic regression analysis to
determine independent factors predictive of PRBC transfu-
sion requirement. A P value <0.05 was considered statisti-
cally significant. All statistical analyses were performed
using SPSS 21.0 (SPSS Inc., Chicago, IL, USA).
Results
The demographic characteristics, preoperative laboratory
findings, and intraoperative variables of the 526 patients
are shown Table 1. During open radical nephrectomy, 93
(17.7 %) patients received PRBC transfusions, with each
receiving a mean 5.5 units of PRBCs. Preoperative hypo-
albuminemia (serum albumin <3.5 g/dL) was observed
Table 1 Characteristics, preoperative laboratory values, and intraoperative variables of patients who were and were not transfused
with PRBC during radical nephrectomy
Non-transfused group (n = 433) Transfused group (n = 93) P value
Age (years) 55.3 ± 12.8 57.6 ± 12.7 0.121
Gender (male/female) 277 (64.0 %) / 156 (36.0 %) 66 (70.9 %) / 27 (29.1 %) 0.199
Body mass index (kg/m2) 24.6 ± 3.4 23.6 ± 3.5 0.011
Hypertension 176 (40.6 %) 37 (39.8 %) 0.878
Diabetes mellitus 68 (15.7 %) 17 (18.3 %) 0.540
Coronary artery disease* 19 (4.4 %) 7 (7.5 %) 0.196
Respiratory disease† 25 (5.8 %) 9 (9.7 %) 0.167
History of abdominal operation 98 (22.6 %) 17 (18.3 %) 0.408
Preoperative laboratory values
Albumin (g/dL) 4.1 ± 0.5 3.6 ± 0.7 <0.001
Albumin <3.5 g/dL 36 (8.3 %) 39 (41.9 %) <0.001
Hemoglobin (g/dL) 13.5 ± 1.9 11.6 ± 2.2 0.009
Hemoglobin <12.0 g/dL 72 (16.6 %) 49 (52.7 %) <0.001
Prothrombin time (INR) 0.99 ± 0.08 1.04 ± 0.10 <0.001
Platelet (×109/L) 253.0 ± 78.1 293.8 ± 129.2 0.004
Creatinine (mg/dL) 1.3 ± 2.0 1.4 ± 2.3 0.965
Uric acid (mg/dL) 5.3 ± 1.5 5.3 ± 1.6 0.258
Crystalloid infused (mL) 1757.6 ± 760.4 3897.3 ± 2758.5 <0.001
Colloid infused (mL) 158.2 ± 268 1145.2 ± 861.9 <0.001
Operative time (min) 193.4 ± 57.7 332.5 ± 171 <0.001
Cancer stage‡ <0.001
I 239 (96.0 %) 10 (4.0 %)
II 67 (82.7 %) 14 (17.3 %)
III 85 (74.6 %) 29 (25.4 %)
IV 38 (52.1 %) 35 (47.9 %)
Urologist 0.570
A 154 (85.6 %) 26 (14.4 %)
B 115 (80.4 %) 28 (19.6 %)
C 73 (80.2 %) 18 (19.8 %)
D 91 (81.3 %) 21 (18.8 %)
Data are expressed as the mean ± standard deviation or number (percentage). *Stenosis of one or more coronary arteries with occlusion of more than 50 % of the
vessel lumen. †Chronic obstructive pulmonary disease, history of tuberculosis, asthma or interstitial lung disease. ‡Based on preoperative imaging [7], except for
nine patients without formal records of imaging findings. PRBC packed red blood cell; INR international normalized ratio
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(hemoglobin <12.0 g/dL) in 121 (23.0 %).
Comparisons between the 93 patients who required
PRBC transfusions and the 433 who did not revealed no
significant differences in demographic characteristics,
except for body mass index (Table 1). However, pre-
operative serum albumin (Fig. 1) and hemoglobin (Fig. 2)
concentrations were significantly lower in the transfused
group than in the non-transfused group.
Univariate logistic regression analysis showed that body
mass index, preoperative hypoalbuminemia, preoperative
anemia, prothrombin time, platelet count, and cancer stage
were significantly related to PRBC transfusion (Table 2).Multivariate logistic regression analysis showed that pre-
operative hypoalbuminemia, preoperative anemia, and
more advanced cancer stage were independent factors
significantly associated with PRBC transfusion in patients
undergoing open radical nephrectomy for renal cell carcin-
oma (Table 2).
There was no significant difference in postoperative
creatinine levels between non-transfused and transfused
groups (1.62 ± 1.90 mg/dL vs. 1.80 ± 2.47 mg/dL, P =
0.507). However, the incidence of pulmonary compli-
cations was significantly higher for the transfused
group than for the non-transfused group (32.3 % vs. 16.4 %,
P <0.001). The rate of ICU admission was significantly
Fig. 1 Box-and-Whisker plots of preoperative albumin levels in patients who were (transfused group) or were not (non-transfused group)
transfused with PRBCs. Note that the preoperative albumin level was significantly lower in the transfused group than in the non-transfused
group. PRBC: packed red blood cell
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longer for the transfused group than for the non-transfused
group (Table 3).
Discussion
The main finding of this study was that preoperative
hypoalbuminemia, anemia and advanced cancer stage
were independent predictors of increased PRBC transfu-
sion requirements and subsequent poor postoperative
outcomes in patients undergoing radical nephrectomy forFig. 2 Box-and-Whisker plots of preoperative hemoglobin levels in patients
transfused with PRBCs. Note that the preoperative hemoglobin level was si
group. PRBC: packed red blood cellrenal cell carcinoma. To the best of our knowledge, this is
the first report showing that preoperative hypoalbumin-
emia and anemia are important predictors of PRBC trans-
fusion requirement in this group of patients.
Renal cell carcinoma accounts for 2 % to 3 % of malig-
nancies in adults, as well as being the third most frequent
and the most lethal form of genitourinary cancer [1, 10].
The only curative therapeutic strategy is the complete
removal of malignant renal tissue [3]. Clavien-Dindo
complications of grade II or higher have been recorded inwho were (transfused group) or were not (non-transfused group)
gnificantly lower in the transfused group than in the non-transfused
Table 2 Logistic regression analyses of factors independently predicting PRBC transfusion during radical nephrectomy
Variables Univariate analysis Multivariate analysis
Odds ratio (95 % CI) P value Odds ratio (95 % CI) P value
Body mass index 0.919 (0.859 - 0.982) 0.013 1.014 (0.927 - 1.109) 0.764
Hypertension 0.965 (0.611 - 1.524) 0.878
Diabetes mellitus 1.201 (0.668 - 2.158) 0.541
Coronary artery disease* 1.769 (0.721 - 4.339) 0.213
Respiratory disease† 1.749 (0.788 - 3.881) 0.170
History of abdominal operation 0.765 (0.432 - 1.355) 0.358
Hypoalbuminemia 7.965 (4.665 - 13.596) <0.001 3.687 (1.758 - 7.736) 0.001
Anemia 5.584 (3.458 - 9.017) <0.001 3.110 (1.635 - 5.918) 0.001
Prothrombin time 754.009 (62.390 - 9112.557) <0.001 2.358 (0.083 - 67.249) 0.616
Platelet 1.004 (1.002 - 1.007) <0.001 1.000 (0.997 - 1.003) 0.985
Cancer stage‡
I 1.00 1.00
II 4.994 (2.123 - 11.749) <0.001 4.822 (1.950 - 11.920) 0.001
III 8.154 (3.813 - 17.439) <0.001 9.431 (4.210 - 21.125) <0.001
IV 22.013 (10.074 - 48.103) <0.001 15.752 (6.835 - 36.302) <0.001
*Stenosis of one or more coronary arteries with occlusion of more than 50 % of the vessel lumen. †Chronic obstructive pulmonary disease, history of tuberculosis,
asthma and interstitial lung disease. ‡Based on preoperative imaging [7]. PRBC, packed red blood cells
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including a requirement for blood transfusion in 11.1 %
[11]. The findings presented here will provide important
clinical information about perioperative management that
may reduce transfusion-related morbidity in patients
undergoing radical nephrectomy.
We found that preoperative hypoalbuminemia was an
independent predictor of a requirement for PRBC transfu-
sion during open radical nephrectomy. Serum albumin
concentration is not only disease-specific but indirectly
reflects the nutritional status of both acutely ill patients in
the ICU and chronically ill patients with gastrointestinal
tract bleeding [12–14]. Hypoalbuminemia may represent
more advanced disease; moreover, because of the lower
oncotic pressure may favor a leak of effective intravascular
volume into the interstitial space, hypoalbuminemia may
induce a hypovolemic state [15]. In patients with hypoal-
buminemia and subsequent hypovolemia, the ensuing loss
of blood during surgery can further reduce the effective
circulating volume [16–18]. Hypoalbuminemic patients
with reduced effective circulating volume are thereforeTable 3 Postoperative outcomes of patients who were and






ICU admission 8 (1.8 %) 34 (36.6 %) <0.001
ICU stay (day) 0.06 ± 0.6 2.1 ± 8.4 <0.001
Hospital stay (day) 8.42 ± 3.0 16.9 ± 15.5 <0.001
Data are expressed as the mean ± standard deviation or number (percentage).
PRBC packed red blood cells, ICU intensive care unitmore likely to require PRBC transfusion. Similarly, pre-
operative comorbid conditions associated with albumin
concentrations <4.0 g/dL independently increase the need
for blood transfusion [19]. Moreover, several studies using
a modified version of the Clavien-Dindo classification
system found that hypoalbuminemia was predictive factor
of post-nephrectomy complications [20, 21]. Albumin level
is also an independent predictor of massive blood transfu-
sion in patients undergoing liver transplantation [22–25].
In agreement with results showing that preoperative
anemia is a significant predictor of perioperative blood
transfusion in patients undergoing elective surgery [26],
the present study showed that preoperative anemia was
significantly associated with a need for PRBC transfusion
in patients undergoing open radical nephrectomy. These
results suggest that patients with a low preoperative
hemoglobin concentration reach a threshold for blood
transfusion more rapidly than patients with a normal
preoperative hemoglobin concentration [27, 28].
Blood transfusion has remained a mainstay for the
management of severely anemic patients and of patients
requiring a rapid increase in hemoglobin concentration
[29]. Transfusion itself, however, carries significant risks
and is associated with postoperative morbidity and mor-
tality [30]. Similar to previous reports [30–32], we found
that the group requiring PRBC transfusions were more
likely to have poor postoperative outcomes, such as
increased rate of postoperative ICU admission and
longer ICU/hospital stay.
The present study found that advanced cancer stage
was a predictor of the requirement of PRBC transfusion.
Kim et al. BMC Anesthesiology  (2015) 15:103 Page 6 of 7Similarly, more advanced clinical T and N stages were
significantly associated with higher rates of blood trans-
fusion and postoperative complications [33]. Because of
the level of tumor thrombus is included in T staging, it
could also influence intraoperative blood loss and subse-
quent need for blood transfusion during surgery [34].
This study has a possible limitation. The present study
was retrospectively designed, so we reviewed medical
records for collecting data. However, the important
perioperative information for the purpose of the present
study is generally well documented.
Conclusion
In conclusion, this study showed that preoperative hypoal-
buminemia and anemia were important predictors of
PRBC transfusion in patients undergoing radical nephrec-
tomy for renal cell carcinoma. Moreover, blood transfu-
sions were associated with poor postoperative outcomes.
Identifying factors predictive of PRBC transfusion can
provide better information about perioperative manage-
ment, which may reduce the need for blood transfusion
and, thus, prevent poor outcomes in patients undergoing
radical nephrectomy.
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